VAI-SU2C Epigenetics Dream Team Archives

May 15, 2017 Dr. Stephen Baylin becomes third VARI-affiliated scientist to be elected to National Academy of Sciences

VARI-affiliated cancer researcher Stephen Baylin, M.D., has been elected to the National Academy of Sciences…

March 7, 2017 New drug combination targets aggressive blood cancer

Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial

GRAND RAPIDS, Mich. (March 7,…

August 29, 2016 Vitamin C may boost effectiveness of acute myeloid leukemia treatment

EDITOR’S NOTE: Maintaining proper nutrition is an important part of cancer therapy. Patients are urged to consult their doctors before making any change to their…

October 20, 2014 Stand Up To Cancer Epigenetics Dream Team continues with $7.5 million funding from Van Andel Research Institute

Grand Rapids, Michigan (October 20, 2014)— The work of one of the Stand Up To Cancer (SU2C) inaugural Dream Teams, launched in 2009 to focus…